Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The case shows the difficulty in diagnosing certain conditions when standard tests are negative.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

The document doesn't say if the treatment for hair loss worked.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Topical Minoxidil is effective for hair loss after COVID-19.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Sex hormones may affect COVID-19 severity and outcomes.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.

Anabolic steroid users may face higher risk of severe COVID-19.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.